Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a $5.7 billion market cap biotechnology company, announced that clinical trials for its gene therapy ELEVIDYS will resume following a favorable review of ...

But she's now talking, thanks to applied behaviour analysis (ABA) therapy in Thunder Bay, Ont., where the four-year-old lives with her parents, and a $190,000 grant the family says they received ...